Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept for NODAT in Renal Transplant
NCT01875224Phase 4Unknown
- Sponsor
- University of Arizona
- Start
- Aug 2013
- Primary completion
- Aug 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of belatacept in kidney transplant rejection, sponsored by University of Arizona. Status: unknown.
02
Drugs
belatacept
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01875224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01875224.